Cowen Upgrades CVS To Outperform

Analysts at Cowen & Company upgraded CVS

from Market Perform to Outperform. The target price for CVS has been raised from $85 to $92. CVS shares have jumped 32.19% over the past 52 weeks, while the S&P 500 index has gained 16.96% in the same period. CVS's shares fell 0.64% to close at $80.57 on Friday.